KIF26B in the Prognosis and Immune Biomarking of Various Cancers: A Pan-Cancer Study.

Sun, Fei; Lian, Yingying; Wang, Jianlin; Hu, Lijun; Luo, Judong; Yu, Jingping.

Afiliação

Sun F; Department of Radiotherapy, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou 213003, Jiangsu Province, China.
Lian Y; Department of Radiotherapy, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou 213003, Jiangsu Province, China.
Wang J; Department of Radiotherapy, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou 213003, Jiangsu Province, China.
Hu L; Department of Radiotherapy, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou 213003, Jiangsu Province, China.
Luo J; Department of Radiotherapy, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou 213003, Jiangsu Province, China.
Yu J; Department of Radiotherapy, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou 213003, Jiangsu Province, China.

J Oncol ; 2022: 4829697, 2022.

Article em En | MEDLINE | ID: mdl-35359341

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article